ArticleNature communications2024

CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma.

Chen-Hui Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.